Follow the 바이오다인 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오다인 has recorded 29 insider filings. Market capitalisation: €243.5bn. The latest transaction was disclosed on 13 July 2026 (Purchase). Among the most active insiders: 임욱빈. All data is openly available.
28
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
10 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,254 of 29,063 companies
52.5
score / 100
Value
32
Quality
73
FCF yld-2.2%
Earn yld0.4%
EV/EBITDA·
ROE3.3%
Gross mgn64%
Net mgn12%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioDine es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el sector médico.